November 23, 2022
Life Sciences
  • The Food and Drug Administration (FDA) approved Hemgenix, an IV treatment for adults with hemophilia B. Shortly after the approval, Drugmaker CSL Behring announced that the drug costs $3.5 million a dose, making it the most expensive medicine in the world. CSL Behring said the price tag is justified because the treatment would ultimately reduce health care costs because patients would have fewer bleeding incidents and need fewer clotting treatments. (Press release here; Articles here and here)